Aurinia Pharmaceuticals Inc. | Cash Flow
Fiscal year is January-December. All values CAD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
2,742.90
18,385.90
23,805.30
30,864.10
91,888.70
83,109
Depreciation, Depletion & Amortization
649.10
1,679.90
1,993.30
1,959.60
1,889.90
2,028.50
Other Funds
-
1,767.10
-
-
-
21,963.20
Funds from Operations
5,802.10
16,206.80
24,291.50
26,740.90
55,643.10
59,117.30
Changes in Working Capital
1,335.40
1,140.90
1,562.10
1,947.60
2,205.30
7,776.90
Net Operating Cash Flow
4,466.70
17,347.70
22,729.40
24,793.30
53,437.80
66,894.20
Capital Expenditures
111.30
99.40
64.00
33.10
32.50
Sale of Fixed Assets & Businesses
70.10
4.40
-
25.20
-
Purchase/Sale of Investments
4.10
11,042.30
34.50
13,245.20
10,355.50
Net Investing Cash Flow
37.10
11,137.30
29.40
13,237.30
10,388.00
Issuance/Reduction of Debt, Net
73.20
1,322.00
-
-
-
Net Financing Cash Flow
6,275.10
51,570.30
1,073.40
56,461.50
227,349.10
Net Change in Cash
1,685.70
23,066.50
21,685.40
44,905.60
163,523.30
Free Cash Flow
4,466.70
17,411.70
22,737.10
24,813.10
53,470.20
Deferred Taxes & Investment Tax Credit
4,029.90
-
-
-
-
-
Change in Capital Stock
6,201.90
54,659.50
1,073.40
56,461.50
227,349.10
Exchange Rate Effect
85.50
18.80
-
-
-
About Aurinia Pharmaceuticals
View Profile
